6 recruiting, 2 active not recruiting, 1 not yet recruiting. 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Not yet recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
Follow UTUC: new trials by email Literature Review of UTUC trials Research Report on UTUC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC Trastuzumab Rezetecan, Gemcitabine, Radical nephroureterectomy - UTUC | Phase 2 | Recruiting | Zhiquan Hu | 54 | 2026-08-15 | 2026-08-03 |
| Screening for Urological Malignancies Using a Urine Exfoliated Cell Fluorescence Assay in a Hematuria Population UTUC, UC (Urothelial Cancer) | Recruiting | Ruijin Hospital | 170 | 2026-04-01 | 2026-09-10 | |
| Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma Gemcitabine, Cisplatin - UTUC, NAC | Phase 2 | Not yet recruiting | Changhai Hospital | 45 | 2025-05-15 | 2025-04-15 |
| Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Upper Tract Urothelial Carcinoma Deep learning system for prognostication prediction in upper tract urothelial carcinoma - UTUC | Active not recruiting | Mingzhao Xiao | 1000 | 2025-01-01 | 2025-05-29 | |
| A Comparative Study of Neoadjuvant Chemotherapy Versus Upfront Radical Surgery for Upper Tract Urothelial Carcinoma NAC - UTUC, UC (Urothelial Cancer) | Active not recruiting | Changhai Hospital | 120 | 2024-05-15 | 2025-09-04 | |
| A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD) NMIBC, MIBC | Recruiting | Peking University First Hospital | 300 | 2024-03-01 | 2025-05-28 | |
| POST URS Chemotherapy Instillation Mitomycin/Gemcitabine, Saline - UTUC | Not applicable | Recruiting | Carmel Medical Center | 264 | 2023-04-17 | 2023-12-20 |
| A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma RC48-ADC and JS001 - Carcinoma, Upper Tract Urothelial Carcinoma | Phase 2 | Recruiting | Jinling Hospital, China | 30 | 2022-11-23 | 2025-01-22 |
| Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis Urothelial Carcinoma (UC), Upper Tract Urothelial Carcinoma | Recruiting | Henan Provincial People's Hospital | 800 | 2019-10-08 | 2026-07-02 |
Carcinoma (1) · Carcinoma, Transitional Cell (1) · Disease (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Urinary Bladder Neoplasms (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Carcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Neoplasms by Site (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Urologic Diseases (2) · Urologic Neoplasms (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Gemcitabine (3) · Cisplatin (1) · Mitomycin (1) · Sodium Chloride (1)
Changhai Hospital (2) · Carmel Medical Center (1) · Henan Provincial People's Hospital (1) · Jinling Hospital, China (1) · Mingzhao Xiao (1) · Peking University First Hospital (1) · Ruijin Hospital (1) · Zhiquan Hu (1)
China (8) · Israel (1)